Yokoyama, M., Terui, Y., Takeuchi, K., Nara, E., Nakano, K., Ueda, K., . . . Hatake, K. (2013). Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. Hindawi Publishing Corporation.
Chicago ZitierstilYokoyama, Masahiro, et al. Infusion Rate Escalation Study of Rituximab in Patients With CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. Hindawi Publishing Corporation, 2013.
MLA ZitierstilYokoyama, Masahiro, et al. Infusion Rate Escalation Study of Rituximab in Patients With CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. Hindawi Publishing Corporation, 2013.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.